Multicriteria optimization methodology in development of HPLC separation of mycophenolic acid and mycophenolic acid glucuronide in human urine and plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 50, Issue 4, 2009, Pages 640-648

  Živanović, Ljiljana ^a   Protić, Ana ^a   Zečević, Mira ^a   Jocić, Biljana ^a   Kostić, Mirjana ^b  

^a Faculty of Pharmacy   (Serbia)

^b UNIVERSITY CHILDREN S HOSPITAL   (Serbia)

Author keywords

Derringer's desirability function; Experimental design; Mycophenolic acid; Mycophenolic acid glucuronide

Indexed keywords

ACETONITRILE; DRUG METABOLITE; MYCOPHENOLIC ACID; MYCOPHENOLIC ACID BETA D GLUCURONIDE; PHOSPHATE; UNCLASSIFIED DRUG;

ACCURACY; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG STRUCTURE; ELUTION; HUMAN; PH; PRIORITY JOURNAL; PROCESS DEVELOPMENT; PROCESS OPTIMIZATION; PRODUCT RECOVERY; REVERSED PHASE HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; SEPARATION TECHNIQUE; TEMPERATURE; VALIDATION PROCESS;

CHROMATOGRAPHY, HIGH PRESSURE LIQUID; GLUCURONIDES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; MYCOPHENOLIC ACID; REPRODUCIBILITY OF RESULTS;

EID: 67949095585     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2008.09.052     Document Type: Article

References (42)

1. Katzung B.G. Basic and Clinical Pharmacology (2004), Lange Medical Books, McGraw-Hill Medical Publishing Division, USA pp. 589-589
2. Tsina I., Chu F., Hama K., Kaloostian M., Tam Y.L., Tarnowski T., and Wong B. J. Chromatogr. B 675 (1996) 119-129
3. Galichet L.Y. Clarke's Analysis of Drugs and Poisons (2004), Pharmaceutical Press, UK pp. 1038-1038
4. Elbarbry F.A., and Shoker A.S. J. Chromatogr. B 859 (2007) 276-281
5. Kuriata-Kordek M., Boratyńska M., Klinger M., Woźniak M., Urbaniak J., Szyber P., Patrzalek D., and Tupka D. Transpl. Proc. 34 (2002) 2985-2987
6. Okamoto M., Wakabayashi Y., Higuchi A., Kadotani Y., Ogino S., Ushigome H., Akioka K., Kaihara S., and Yoshimura N. Transpl. Proc. 37 (2005) 859-860
7. Elbarbry F., and Shoker A. Clin. Biochem. 40 (2007) 752-764
8. Saavedra L., and Barbas C. J. Chromatogr. B 766 (2002) 235-242
9. Orlandini S., Giannini I., Pinzauti S., and Furlanetto S. Talanta 74 (2008) 570-577
10. Svensson J., Brattstrom C., and Sawe J. Ther. Drug Monit. 21 (1999) 322-324
11. Behrami G., and Mohammadi B. Clin. Chim. Acta 370 (2006) 185-190
12. Huang J.Z., Kijang H., and Tarnowski T.L. J. Chromatogr. B 698 (1997) 293-300
13. Hosotsubo H., Takahara S., Kokado Y., Permpongkosol S., Wang J.D., Tanaka T., Matsumiya K., Kitamura M., Okuyama A., and Sugimoto H. J. Pharm. Biomed. Anal. 24 (2000) 555-560
14. Tsina I., Kaloostin M., Lee R., Tarnowski T., and Wong B. J. Chromatogr. B 681 (1996) 347-353
15. Aresta A., Palmisano F., Zambonin C.G., Schena P., and Grandalino G. J. Chromatogr. B 810 (2004) 197-202
16. Minoa Y., Naito T., Matsushita T., Kagawa Y., and Kawakami J. J. Pharm. Biomed. Anal. 46 (2008) 603-608
17. Yau W.P., Vathsala A., Lou H.X., and Chan E. J. Chromatogr. B 805 (2004) 101-112
18. Bolon M., Jeanpierre L., El Barkil M., Chelbi K., Sauviat M., and Boulieu R. J. Pharm. Biomed. Anal. 36 (2004) 649-651
19. Loor H., Naesens M., Verbeke K., Vanrenterghem Y., and Kuypers D.R. Clin. Chim. Acta 389 (2008) 87-92
20. Watson D.G., Araya F.G., Galloway P.J., and Beattie T.J. J. Pharm. Biomed. Anal. 35 (2004) 87-92
21. Wiwattanawongsa K., Heinzen E.L., Kemp D.C., Dupuis R.E., and Smith P.C. J. Chromatogr. B 763 (2001) 35-45
22. Wai-Ping Y., Vathsala A., Heui-Xin L., and Shu Feng Z. J. Chromatogr. B 846 (2007) 313-318
23. Khoschsorur G.A., and Erwa W. J. Chromatogr. B 799 (2004) 355-360
24. Indjova D., Kassabova L., and Svinarov D. J. Chromatogr. B 817 (2005) 327-330
25. Westley I.S., Sallustio B.C., and Morris R.G. Clin. Biochem. 38 (2005) 824-829
26. Brandhorst G., Streit F., Goetze S., Oellerich M., and Armstrong V.W. Clin. Chem. 52 (2006) 1962-1964
27. Benoit-Biancamano M.O., Caron P., Lévesque E., Delage R., Couture F., and Guillemette C. J. Chromatogr. B 858 (2007) 159-167
28. Atcheson B., Taylor P.J., Mudge D.W., Johnson D.W., Pillans P.I., and Tett S.E. J. Chromatogr. B 799 (2004) 157-163
29. Patel C.G., Mendonza A.E., Akhlaghi F., Majid O., Trull A.K., Lee T., and Holt D.W. J. Chromatogr. B 813 (2004) 287-294
30. Guidance for Industry: Bioanalytical Method Validation, US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research, Rockville, MD, 2001, http://www.fda.gov/eder/guidance/4252fnl.htm.
31. ICH Topic Q2 (R1) Validation of Analytical Procedures: Text and Methodology, version 4, 2005, http://www.ich.org/cache/compo/276-254-1.html.
32. Rueda M.E., Sarabia L.A., Herrero A., and Ortiz M.C. Anal. Chim. Acta 479 (2003) 173-184
33. Brereton R.G. Chemometrics - Data Analysis for the Laboratory and Chemical Plant (2003), John Wiley & Sons Ltd., Chichester, England pp. 76-77
34. Preu M., Guyot D., and Petz M. J. Chromatogr. A 818 (1998) 95-108
35. Martendal E., Budziak D., and Carasek E. J. Chromatogr. A 1148 (2007) 131-136
36. Deming S.N., and Morgan S.L. In: Vandeginste B.G.M., and Rutan S.C. (Eds). Experimental Design: A Chemometric Approach. second ed. (1993), Elsevier, Amsterdam, The Netherlands 334-336
37. Bourdat-Deschamps M., Daudin J.J., and Barriuso E. J. Chromatogr. A 1167 (2007) 143-153
38. Candioti L.V., Robles J.C., Mantovani V.E., and Goicoechea H.C. Talanta 69 (2006) 140-147
39. Nowak M., and Seubert A. J. Chromatogr. A 855 (1999) 91-109
40. Ferreiros N., Iriarte G., Alonso R.M., and Jimenez R.M. Talanta 69 (2006) 747-756
41. Sivakumar T., Manavalan R., Muralidharan C., and Valliappan K. J. Pharm. Biomed. Anal. 43 (2007) 1842-1848
42. Živanović L., Ličanski A., Zečević M., Jocić B., and Kostić M. J. Pharm. Biomed. Anal. 47 (2008) 575-585